QV Bioelectronics receives £860k Innovate UK funding grant

QV Bioelectronics (QV), creators of a surgically implanted Electric Field Therapy (EFT) device for the treatment of brain tumours – has been awarded a...

Sirius Medical gains $13m for surgical navigation software

Funds from the series B round will help the surgical guidance company develop its lead product Pintuition. Sirius Medical has announced the closure of a...

SolasCure announces final closing of GBP 10.9m (c. USD 13.3m) Series B fundraise to advance wound care innovation

SOLASCURE Ltd (SolasCure), a biotechnology company developing a hydrogel containing a recombinant enzyme derived from maggots which aims to accelerate wound debridement, has announced...

INVO Bioscience Announces Closing Of $3.0 Million Registered Direct Offering

INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical...

Vital Secures $24.7 Million in Series B Funding

 Vital, a leading artificial intelligence (AI)-driven digital health company improving the patient experience, announced that it has raised $24.7 million in Series B funding...

Protai Adds $12 Million to Seed Round – Bringing the Total to $20 Million

Since its initial funding last year, Protai has launched collaborations with leading hospitals, opened a wet lab and expanded its advisory board with world-renowned...

Neurotechnology company Cognito Therapeutics scores $73M

The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease. Cognito Therapeutics, a startup using visual...

ThoughtFull gets $4M funding from Temasek’s Sheares, other tech founders

It also received backing from the founders of Grab and Zalora. Singapore-based digital mental health company ThoughtFull has raised $4 million in a pre-Series A...

Vitestro raises EUR 12 million in Series A financing round to bring the world’s first autonomous blood drawing device to the European market

Vitestro, developer of an autonomous blood drawing device, announces the completion of a EUR 12 million Series A financing round. California-based Sonder Capital led...

Latest articles